INTRODUCTION Non-small cell lung cancer (NSCLC) is the most common form of lung cancer in the developed world. When the tumor is localized, surgery remains the gold standard. Historically, pulmonary lobectomy has been the procedure of choice.1 With the advancement of low-dose thoracic computed tomography (CT), three-dimensional (3D) reconstruction software, and the increasing trend toward minimally invasive surgery, the current trend has shifted toward parenchymal preservation.